Wegovy price in Spain (2026): €179.89 to €223.64 per pen and why it isn't publicly funded

A Wegovy pen costs between €179.89 and €223.64 in Spanish pharmacies, depending on the dose. Each pen holds 4 weekly doses, so it lasts 4 weeks. For the first three doses of the escalation you pay €179.89 every 4 weeks, and for the 2.4 mg maintenance dose you pay €223.64. Spain's National Health System (Seguridad Social) doesn't fund it, so the patient pays the full price, and you need a doctor's prescription.

Wegovy is semaglutide injected once a week and is authorised in Spain for weight management. Below you'll find the price of each pen with its national code (CN), the monthly cost at each stage of treatment, what is known about the new 7.2 mg dose and what Spain's Ministry of Health says about funding it.

How much does each Wegovy pen cost at the pharmacy?

These are the retail prices including VAT that Vademecum publishes for Wegovy FlexTouch pens, checked on 5 November 2026. Each pack contains one pen:

• Wegovy 0.25 mg (national code 758085): €179.89.
• Wegovy 0.5 mg in a 3 ml pen (CN 767530): €179.89.
• Wegovy 1 mg (CN 758087): €179.89.
• Wegovy 1.7 mg (CN 758088): €200.19.
• Wegovy 2.4 mg (CN 758089): €223.64.

The three lowest doses cost the same, and the price only goes up for the last two. The price isn't regulated. Because Wegovy isn't funded, it doesn't appear in the Ministry of Health's Nomenclátor, which only lists products covered by the National Health System's (SNS) pharmaceutical benefit. If you search for "WEGOVY" there, the result is "No se han obtenido datos" (no data found). That's why the price reference here is Vademecum and not an official Ministry list. Vademecum gives no price for the 0.5 mg pen in 1.5 ml (CN 758086). The 0.5 mg pen with a published price is the 3 ml one.

How many weeks does a Wegovy pen last?

According to the AEMPS summary of product characteristics (SmPC), each FlexTouch pen contains 4 doses of its strength. The 0.25 mg pen holds four 0.25 mg doses, the 2.4 mg pen holds four 2.4 mg doses, and so on. Because the injection is weekly, one pen lasts 4 weeks.

That detail changes the yearly total. A calendar month is a little longer than four weeks, so 52 weeks use 13 pens, not 12. When you see "price per month", it really means "price every 4 weeks". To work out the cost of a year, multiply it by 13, not 12.

How much does Wegovy cost per month at each stage of treatment?

The SmPC describes a 16-week dose escalation up to the maintenance dose, designed to reduce digestive side effects: 0.25 mg in weeks 1 to 4, 0.5 mg in weeks 5 to 8, 1 mg in weeks 9 to 12 and 1.7 mg in weeks 13 to 16, then 2.4 mg. This is what the SmPC sets out. It isn't a dosing plan for any individual patient. The doctor decides the pace, and the SmPC itself allows for delaying a dose increase or going back to the previous dose if digestive symptoms are significant. With that escalation and Vademecum's prices, the costs are:

• Weeks 1 to 12, with the 0.25, 0.5 and 1 mg pens: €179.89 every 4 weeks.
• Weeks 13 to 16, with the 1.7 mg pen: €200.19.
• From week 17, with the 2.4 mg maintenance pen: €223.64 every 4 weeks.

In total, the 16 weeks of escalation cost €739.86. A full first year, escalation included, takes 13 pens and costs €2,752.62. A full year on the 2.4 mg maintenance dose costs €2,907.32. If the doctor keeps you on an intermediate dose for longer, the cost of that period depends on which pen you're using, because each pen is bought and paid for separately.

What about the 7.2 mg dose of Wegovy, and how much does it cost?

It exists and is on sale. CIMA, the AEMPS medicines register, lists Wegovy 7.2 mg solution for injection in pre-filled pen, in a box of 4 single-dose pens (CN 771404). It was authorised on 22 July 2026 and is marked as marketed as of 5 November 2026, as it is in BOT Plus, the database of Spain's General Council of Official Pharmacists' Associations. Unlike the FlexTouch pens, each of these pens holds a single injection, so the whole box covers 4 weeks.

The SmPC restricts this dose to adults who started treatment with a BMI of 30 or more and have had at least 4 weeks on 2.4 mg. It provides for going back to 2.4 mg if 7.2 mg brings no further improvement in weight. We haven't been able to verify its price because we couldn't find it published in any reliable source, so we don't give a figure. If a doctor suggests it to you, the pharmacy can tell you the exact price.

Why doesn't Spain's National Health System fund Wegovy?

Because the Ministry of Health formally decided not to include it in the pharmaceutical benefit. BIFIMED, the Ministry's funding search tool, lists Wegovy as "No financiado por resolución" (not funded, by formal decision). This applies from 1 April 2023 for the 0.25, 1, 1.7 and 2.4 mg pens, from 1 November 2025 for the 0.5 mg pen in 3 ml and from 1 September 2026 for the 7.2 mg pen.

BIFIMED also lists each authorised indication and the decision on it. There are three: weight management in adults with obesity (BMI of 30 or more); weight management in adults with overweight (BMI of 27 to under 30) and at least one weight-related condition, such as prediabetes, type 2 diabetes, high blood pressure, dyslipidaemia, sleep apnoea or cardiovascular disease; and weight management in adolescents aged 12 and over with obesity and a body weight above 60 kg. All three are listed as "No incluida" (not included). BIFIMED's entry doesn't give the reasons for the decision, only the decision itself. The public report section is empty.

In practice, there is no reduced co-payment to lower the cost, the price isn't regulated and the buyer pays the full amount. This is the difference from Ozempic, the same molecule authorised for type 2 diabetes. Ozempic is funded for certain indications with prior authorisation (visado). Its prices are in the guide to the price of Ozempic per pen.

Do you need a prescription to buy Wegovy?

Yes. CIMA classifies both the pens and the tablets as prescription-only medicines, and BIFIMED confirms this with "Receta: sí" (prescription: yes). Not being funded doesn't change that. A doctor has to assess your case and prescribe it, and then you pay the full price at the pharmacy with your prescription.

You can't buy it online either. Article 3.5 of Spain's Medicines Guarantees Act bans the online sale of medicines that need a prescription. In September 2025 the AEMPS warned of a rise in illegal products sold as GLP-1 drugs on websites and social media, which may not contain what they claim. We explain how to recognise the legal route in buying Ozempic and Mounjaro legally in Spain.

How much do Wegovy tablets cost?

Wegovy also comes as once-daily tablets of 1.5, 4, 9 and 25 mg in packs of 30. According to CIMA they are marketed in Spain, and they aren't funded either. The only price available is for the 25 mg tablets, around €236 per pack, from press reports. The other strengths have no verified price.

How does the price of Wegovy compare with Mounjaro?

For your wallet, the two brands work the same way. Mounjaro isn't funded either (BIFIMED has listed it as "No financiado por resolución" since 1 July 2024), its pen also holds 4 doses and the price changes as the dose goes up. The breakdown by dose is in how much Mounjaro costs per month in Spain. For a fair comparison, always use the same period, every 4 weeks, and the maintenance dose that would apply in each case. Don't compare the starting doses, which for both drugs are the cheapest and are used for the shortest time.

If you're interested in the tablet version, there's a separate article on what we know about the price of Wegovy tablets and getting a prescription.

Key takeaways

Three facts explain the price of Wegovy. Each pen covers 4 weeks, it costs €179.89 to €223.64 depending on the dose and it isn't funded, so a year on maintenance costs €2,907.32. If you want to lose weight with medical support, Spain currently offers medical weight-loss treatment. It starts with an assessment, a registered doctor prescribes treatment if appropriate and you have ongoing follow-up. You can:

Check in a few minutes whether you're eligible